Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma.
OBJECTIVE
To clarify the relationship between the loss of expression of the deleted in pancreatic carcinoma locus 4 (DPC4) proteins and the pathogenesis of biliary tract carcinoma.


METHODS
71 primary biliary tract carcinoma (BTCa), including 38 common bile duct (CBD) carcinomas, 18 gallbladder carcinomas, 15 hilar bile ducts (HBD) carcinomas were examined by immunohistochemical staining. In addition, the CBD carcinomas were divided into two groups: tumors with metastasis (M(+) group, 27 cases) and tumors without metastasis (M(-) group, 11 cases).


RESULTS
The frequency of loss of the expression of DPC4 protein was 32.8% in BTCa, 47.3% in CBD carcinoma, 11% in gallbladder carcinoma, 13% in HBD carcinoma. Comparison of the frequency of loss expression of DPC4 was significant statistical difference in CBD carcinoma versus gallbladder carcinoma and HBD carcinoma (P < 0.01). The frequency of loss expression of DPC4 was 48.1% in the M(+) group and 45.4% in the M(-) group.


CONCLUSIONS
There are a close relationship between pathogenesis of BTCa and inactivation of DPC4 and different frequencies of DPC4 gene alternation in various locations of the biliary tract, which are not significantly increased with tumor metastasis in BTCa.
Tang
Zhaohui
Z
Department of General Surgery, Tongji Hospital, Wuhan 430030, China (Email: tangzh45@sina.com)
Zou
Shengquan
S
Hao
Youhua
Y
Wang
Baoju
B
Yang
Xiangping
X
Qiu
Fazu
F
D001650:Bile Duct Neoplasms; D001659:Biliary Tract; D002277:Carcinoma; D004268:DNA-Binding Proteins / Q000378:metabolism; D006801:Humans; D010190:Pancreatic Neoplasms; D051901:Smad4 Protein; D015534:Trans-Activators
D004268:DNA-Binding Proteins; D051901:Smad4 Protein; D015534:Trans-Activators